'Fen-phen' refers to the off-label combination of the appetite suppressants
fenfluramine and phentermine. The rationale for the fen-phen combination w
as that the two drugs exerted independent actions on brain satiety mechanis
ms so that it was possible to use lower doses of each drug and yet retain a
common action on suppressing appetite while minimizing adverse drug effect
s. The focus of the present review is to consider whether fenfluramine and
phentermine exert actions that are additive in nature or whether these two
drugs exhibit drug-drug synergism. The fen-phen combination results in syne
rgism for the suppression of appetite and body weight, the reduction of bra
in serotonin levels, pulmonary vasoconstriction and valve disease. Fen-phen
synergism may reflect changes in the pharmacokinetics of drug distribution
, common actions on membrane ion currents, or interactions between neuronal
release and reuptake mechanisms with MAO-mediated transmitter degradation.
The synergism between fenfluramine and phentermine highlights the need to
more completely understand the pharmacology and neurochemistry of appetite
suppressants prior to use in combination pharmacotherapy for the treatment
of obesity.